PL2970210T3 - Pochodne pirazolilobenzo[d]imidazolu - Google Patents

Pochodne pirazolilobenzo[d]imidazolu

Info

Publication number
PL2970210T3
PL2970210T3 PL14712781T PL14712781T PL2970210T3 PL 2970210 T3 PL2970210 T3 PL 2970210T3 PL 14712781 T PL14712781 T PL 14712781T PL 14712781 T PL14712781 T PL 14712781T PL 2970210 T3 PL2970210 T3 PL 2970210T3
Authority
PL
Poland
Prior art keywords
pyrazolylbenzo
imidazole derivatives
imidazole
derivatives
Prior art date
Application number
PL14712781T
Other languages
English (en)
Inventor
Daria Zdżalik
Joanna Lipner
Maciej Wieczorek
Karolina Dzwonek
Abdellah Yamani
Krzysztof Dubiel
Monika Lamparska-Przybysz
Paulina Grygielewicz
Aleksandra Stańczak
Original Assignee
Celon Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celon Pharma S.A. filed Critical Celon Pharma S.A.
Publication of PL2970210T3 publication Critical patent/PL2970210T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL14712781T 2013-03-14 2014-03-07 Pochodne pirazolilobenzo[d]imidazolu PL2970210T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL403149A PL403149A1 (pl) 2013-03-14 2013-03-14 Nowe związki pochodne pirazolilobenzo[d]imidazolu

Publications (1)

Publication Number Publication Date
PL2970210T3 true PL2970210T3 (pl) 2017-09-29

Family

ID=50382512

Family Applications (2)

Application Number Title Priority Date Filing Date
PL403149A PL403149A1 (pl) 2013-03-14 2013-03-14 Nowe związki pochodne pirazolilobenzo[d]imidazolu
PL14712781T PL2970210T3 (pl) 2013-03-14 2014-03-07 Pochodne pirazolilobenzo[d]imidazolu

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL403149A PL403149A1 (pl) 2013-03-14 2013-03-14 Nowe związki pochodne pirazolilobenzo[d]imidazolu

Country Status (20)

Country Link
US (1) US9776988B2 (pl)
EP (1) EP2970210B1 (pl)
JP (1) JP6594779B2 (pl)
KR (1) KR102266546B1 (pl)
CN (1) CN105008348B (pl)
AU (1) AU2014229401B2 (pl)
BR (1) BR112015023092B1 (pl)
CA (1) CA2900629C (pl)
DK (1) DK2970210T3 (pl)
EA (1) EA026782B1 (pl)
ES (1) ES2622376T3 (pl)
HR (1) HRP20170190T1 (pl)
HU (1) HUE031368T2 (pl)
IL (1) IL241234A0 (pl)
MX (1) MX364172B (pl)
PL (2) PL403149A1 (pl)
PT (1) PT2970210T (pl)
SI (1) SI2970210T1 (pl)
WO (1) WO2014141015A1 (pl)
ZA (1) ZA201507548B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3296297A1 (en) * 2016-09-15 2018-03-21 Centre National De La Recherche Scientifique Benzimidazol derivatives for treating filovirus infection
CN107698538B (zh) * 2016-11-30 2020-02-14 内蒙古京东药业有限公司 罗沙替丁醋酸酯盐酸盐的中间体3-(1-哌啶甲基)苯酚的制备方法
CN107163030B (zh) * 2017-06-20 2020-03-24 河南工业大学 具有吡唑母核的小分子杂环化合物及其用于制备抗菌、抗肿瘤药物的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE321044T1 (de) 1999-08-02 2006-04-15 Ortho Mcneil Pharm Inc C-6 ringsubstituierte pyrido(1,2- a)benzimidazolderivate zur behandlung von störungen des zentralen nervensystems
FR2831536A1 (fr) * 2001-10-26 2003-05-02 Aventis Pharma Sa Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
US6897208B2 (en) 2001-10-26 2005-05-24 Aventis Pharmaceuticals Inc. Benzimidazoles
WO2006033943A2 (en) * 2004-09-17 2006-03-30 Exelixis, Inc Pyrazole kinase modulators and methods of use
EP2395000A1 (en) 2004-12-30 2011-12-14 Astex Therapeutics Limited Benzimidazole compounds that modulate the activity of CDK, GSK and aurora kinases
WO2007077435A1 (en) * 2005-12-30 2007-07-12 Astex Therapeutics Limited Pharmaceutical compounds
US7737149B2 (en) * 2006-12-21 2010-06-15 Astrazeneca Ab N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
WO2009153592A1 (en) * 2008-06-19 2009-12-23 Astrazeneca Ab Pyrazole compounds 436
EP2649062B1 (en) * 2010-11-30 2015-04-08 Takeda Pharmaceutical Company Limited Bicyclic compounds as inhibitors of acetyl-coa carboxylase (acc)
ES2651143T3 (es) * 2011-05-13 2018-01-24 Glaxosmithkline Biologicals Sa Antígenos de F de prefusión del VRS

Also Published As

Publication number Publication date
IL241234A0 (en) 2015-11-30
DK2970210T3 (en) 2017-04-10
PL403149A1 (pl) 2014-09-15
EP2970210B1 (en) 2017-01-04
CA2900629A1 (en) 2014-09-18
MX364172B (es) 2019-04-15
HRP20170190T1 (hr) 2017-04-07
KR102266546B1 (ko) 2021-06-21
EA026782B1 (ru) 2017-05-31
MX2015012346A (es) 2016-02-03
BR112015023092B1 (pt) 2021-11-16
PT2970210T (pt) 2017-04-07
ZA201507548B (en) 2017-02-22
AU2014229401A1 (en) 2015-08-20
JP6594779B2 (ja) 2019-10-23
BR112015023092A2 (pt) 2017-07-18
EP2970210A1 (en) 2016-01-20
SI2970210T1 (sl) 2017-05-31
AU2014229401B2 (en) 2018-05-17
HUE031368T2 (en) 2017-07-28
WO2014141015A1 (en) 2014-09-18
EA201591617A1 (ru) 2016-01-29
CN105008348B (zh) 2018-07-10
JP2016516024A (ja) 2016-06-02
US20160039794A1 (en) 2016-02-11
CN105008348A (zh) 2015-10-28
ES2622376T3 (es) 2017-07-06
KR20150126893A (ko) 2015-11-13
US9776988B2 (en) 2017-10-03
CA2900629C (en) 2020-12-15

Similar Documents

Publication Publication Date Title
IL240863B (en) Amatoxin derivatives
SG11201506100XA (en) Pyridazinone-amides derivatives
IL240327A0 (en) New pyrazole derivatives
ZA201601333B (en) Oxoquinazolinyl-butanamide derivatives
EP2905279A4 (en) imidazole
IL241293A0 (en) triazole derivatives
SG11201605189YA (en) Imidazopyrazinone derivatives
IL241859B (en) Novel triazole derivatives
ZA201507146B (en) Pyrazole derivative
ZA201507548B (en) Pyrazolylbenzo[d]imidazole derivatives
GB201219296D0 (en) Pyrazole derivatives
GB201219289D0 (en) Pyrazole derivatives
GB201218245D0 (en) Pyrazole derivatives
GB201314960D0 (en) Heterocyclic derivatives
GB201300306D0 (en) Heterocyclic derivatives
GB201310577D0 (en) Secnidazole